Avadel Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -573%. Total operating expenses were $164,966,000.
Profit Margin
| 2014 | 14.77M | -84.90M | -574.66% |
|---|---|---|---|
| 2015 | 173.20M | 40.65M | 23.47% |
| 2016 | 150.24M | -41.27M | -27.47% |
| 2017 | 172.74M | 67.25M | 38.93% |
| 2018 | 103.26M | -95.30M | -92.29% |
| 2019 | 59.21M | -33.22M | -56.11% |
| 2020 | 22.33M | 7.02M | 31.47% |
| 2021 | 0 | -77.32M | |
| 2022 | 0 | -137.46M | |
| 2023 | 27.96M | -160.27M | -573.17% |
AVDL Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 27.96M | 0 | 0 | 22.33M | 59.21M | 103.26M | 172.74M | 150.24M | 173.20M | 14.77M |
Cost of revenue | 846K | 1.49M | 815K | 5.74M | 12.12M | 17.51M | 16.30M | 13.24M | 10.92M | 3.38M |
Gross profit | 27.11M | -1.49M | -815K | 16.59M | 47.09M | 85.75M | 156.44M | 136.99M | 162.28M | 11.39M |
Operating exp. | ||||||||||
Research and development | 13.26M | 20.7M | 17.10M | 20.44M | 32.91M | 39.32M | 34.21M | 34.61M | 25.60M | 17.29M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 164.96M | 95.21M | 85.59M | 53.25M | 63.91M | 146.30M | 96.73M | 92.67M | 59.88M | 44.74M |
Operating income | -137.84M | -98.56M | -85.54M | -36.66M | -16.82M | -104.92M | 88.3M | -4.96M | 71.44M | -93.85M |
Other income (expenses), net | -22.92M | -12.87M | -7.59M | -10.89M | -21.75M | -42.02M | 3.15M | -53.07M | 6.25M | 3.32M |
Income before tax | -160.77M | -111.43M | -93.14M | -5.08M | -38.58M | -113.19M | 91.46M | -9.71M | 78.39M | -90.33M |
Income tax expense | -501K | 26.02M | -15.81M | -12.11M | -5.35M | -17.89M | 24.21M | 31.55M | 37.73M | -1.40M |
Net income | -160.27M | -137.46M | -77.32M | 7.02M | -33.22M | -95.30M | 67.25M | -41.27M | 40.65M | -84.90M |
Earnings per share | ||||||||||
Basic EPS | -2 | -2.29 | -1.32 | 0.13 | -0.89 | -2.55 | 1.66 | -1 | 1 | -2.34 |
Diluted EPS | -2 | -2.29 | -1.32 | 0.13 | -0.89 | -2.55 | 1.61 | -1 | 0.93 | -2.34 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |